Echo Therapeutics Inc. will receive $10 million cash investment from Medical Technologies Innovation Asia and its affiliate Platinum Partners. Terms of the deal were disclosed in documents filed Thursday with the Securities and Exchange Commission by Echo (NASDAQ: ECTE), a Philadelphia medical-device company. Under the 10-year agreement, Echo granted Medical Technologies Innovation Asia of Hong Kong the rights to develop, manufacture, market and distribute Echo’s Symphony CGM System on an exclusive basis for the Chinese market — including the Peoples’ Republic of China, Hong Kong, Macau and Taiwan.
Help employers find you! Check out all the jobs and post your resume.
